JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: A previous case-control study by Gorre et al. [16] showed that an increase in JAK2 gene expression occurred at the diagnosis of CML and during treatment, but no significant relationship was found between JAK2 gene expression and molecular response [16].